Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
HYLAN G-F 20
Synvisc-One
Osteoarthritis
SYNV04910NANCT01618708Tabulated Results
HYLAN G-F 20
Synvisc
Osteoarthritis
SYNVIL06244NANCT01586338Tabulated Results
IDRABIOTAPARINUX
Not Marketed
Deep Venous Thrombosis
EFC10295BOREALIS-AFEudraCT: 2007-004817-33Summary results
IDRABIOTAPARINUX
Not Marketed
Deep Venous Thrombosis
EFC5945EQUINOXNCT00311090Publication's reference
IDRABIOTAPARINUX
Not Marketed
Deep Venous Thrombosis
EFC6034CASSIOPEANCT00345618Publication's reference
IGLARLIXI
Soliqua
TYPE 2 DIABETES
OBS16994SIMPLIFY JAPANjRCT1041210151jRCT1041210151
IKK INHIBITOR
Not Marketed
Osteoarthritis
ACT12505NANCT01598415Summary
IKK INHIBITOR
Not Marketed
Osteoarthritis
TDU10820NANCT01113333Summary
IKK INHIBITOR
Not Marketed
Osteoarthritis
TDU11333NANCT01511549Summary
IKK INHIBITOR
Not Marketed
Osteoarthritis
TDU11685NAEudraCT: 2011-003232-31Summary Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted